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Bam32 Links the B Cell Receptor to ERK and JNK
and Mediates B Cell Proliferation but Not Survival
together different enzymatic cascades and by recruiting
signaling molecules to the membrane (Jordan et al.,
2003; Kelly and Chan, 2000; Kurosaki, 2002). For exam-
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rich target domain for protein tyrosine kinases, a proline-2 Howard Hughes Medical Institute
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acts with phosphotyrosine (Fu et al., 1998; Goitsuka et3 Laboratory of Lymphocyte Signaling
al., 1998; Wienands et al., 1998). When phosphorylatedThe Rockefeller University
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which results in the activation of PLC2 and diversifica-
tion of the response by initiating Ca2 flux and activating
protein kinase C  (PKC) and thereby NFB (Fu et al.,Summary
1998; Ishiai et al., 1999; Jumaa et al., 2001; Kurosaki
and Tsukada, 2000; Saijo et al., 2002). BLNK and itsBam32 is an adaptor protein recruited to the plasma
associated proteins are essential for B cell proliferation,membrane upon B cell receptor (BCR) crosslinking in
development, and survival (Cheng et al., 1995; Frumana phosphoinositol 3-kinase (PI3K)-dependent manner;
et al., 2000; Ishiai et al., 1999; Jumaa et al., 1999; Kaishohowever, its physiologic function is unclear. To deter-
et al., 2001; Kerner et al., 1995; Khan, 2001; Kurosakimine its physiologic function, we produced Bam32-
and Tsukada, 2000; Pasparakis et al., 2002; Saijo et al.,deficient mice. Bam32/ B cells develop normally but
2002; Wang et al., 2000; Xu et al., 2000).have impaired T-independent antibody responses in
Bam32, also known as Dapp1 or PHISH, is a recentlyvivo and diminished responses to BCR crosslinking in
described adaptor consisting of an N-terminal SH2 do-vitro. Biochemical analysis revealed that Bam32 acts
main and a C-terminal pleckstrin homology (PH) domainin a novel pathway leading from the BCR to MAPK/
and is recruited to the cell membrane in a PI3K-depen-ERK Kinases (MEK1/2), MAPK/ERK Kinase Kinase-1
dent manner following BCR crosslinking (Anderson et(MEKK1), extracellular signal-regulated kinase (ERK),
al., 2000; Dowler et al., 1999; Marshall et al., 2000a; Niiroand c-jun NH2-terminal kinase (JNK), but not p38 mito-
et al., 2002; Rao et al., 1999). Bam32 is expressed ingen-activated protein kinase (p38). This pathway ap-
B cells and appears to function as a dual adaptor forpears to be initiated by hematopoietic progenitor ki-
phosphotyrosine and 3-phosphoinosides, but its physi-nase-1 (HPK1), which interacts directly with Bam32,
ologic function has not been determined. To examineand differs from all previously characterized BCR sig-
the role of Bam32 in B cell development and function,naling pathways in that it is required for normal BCR-
we used gene targeting to produce Bam32 null mutantmediated proliferation but not for B cell survival.
mice. Here, we report that Bam32 links the BCR to ERK
and JNK through a novel pathway. This pathway is re-Introduction
quired for normal B cell proliferative responses but not
for B cell survival.The B cell receptor (BCR) is essential for B cell develop-
ment, specific response to antigen, and survival
Results
(Benschop and Cambier, 1999; King and Monroe, 2000;
Kurosaki, 2000; Niiro and Clark, 2002; Rajewsky, 1996;
Bam32 Expression in Mice
Reth et al., 2000). These diverse functions are mediated
In humans, Bam32 is largely restricted to hematopoietic
by a receptor that is composed of membrane bound cells with the exception of T cells, and its expression
immunoglobulin (mIg) and an associated signal trans- is thought to be enhanced in germinal center B cells
ducer composed of the Ig-Ig dimer (Hermanson et (Marshall et al., 2000a). In mice, we found the expression
al., 1988; Hombach et al., 1988; Sakaguchi et al., 1988). of Bam32 to be similar to what was reported in humans,
The Ig-Ig dimer initiates BCR signaling by recruiting with some notable differences. We detected no increase
and activating Src family, Syk, and Btk tyrosine kinases in Bam32 mRNA in isolated germinal center B cells or
(Kurosaki, 2000; Niiro and Clark, 2002). These BCR prox- activated splenic B cells, including those stimulated with
imal protein tyrosine kinases (PTKs) phosphorylate a anti-CD40, anti-CD40  anti-IgM, or anti-CD40  IL-4
number of cellular substrates, leading to activation of (Figure 1). Rather, in comparison with naive splenic B
phosphoinositol 3-kinase (PI3K), AKT/Protein Kinase B cells, B cells that were stimulated with LPS, anti-CD40,
(AKT), phospholipase Cgamma2 (PLC2), intracellular anti-IgM, or isolated germinal center B cells expressed
Ca2 mobilization, and nuclear mediators of survival and reduced levels of Bam32 mRNA. We also found murine
proliferation including NFB and mitogen-activated pro- Bam32 to be expressed in thymus and in isolated thymic
tein kinases (MAPKs) (Chang and Karin, 2001; Karin and and splenic T cells, albeit at lower levels than were
Lin, 2002; Kurosaki, 2000; Niiro and Clark, 2002). observed in B cells (Figure 1). We conclude that in mice,
Adaptor proteins diversify BCR signaling by linking Bam32 is largely restricted to hematopoietic cells with
particularly high expression in B cells, and that expres-
sion is not enhanced with B cell activation.*Correspondence: nussen@mail.rockefeller.edu
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Figure 1. Expression of Bam32 in Mice
Quantitative RT-PCR analysis on tissues (top), B cells (middle), and isolated cells from spleen and thymus (bottom). B cells were purified from
resting spleen and cultured in the presence various stimuli, or isolated from splenic germinal centers as indicated. Results are expressed as
relative units of Bam32 mRNA normalized using GAPDH mRNA. Data shown are representative of two independent experiments.
Bam32-Deficient Mice Bam32 Is Essential for Normal T-Independent
Immune ResponsesTo examine the function of Bam32 in vivo, we targeted
Bam32 by replacing exon 1 with a neomycin resistance To determine whether Bam32 is essential for B cell re-
sponses to antigen in vivo, we immunized mice withcassette (Figures 2A and 2B). Stop codons are present
in all reading frames 3 to the neomycin resistance cas- 4-hydroxy-3-nitrophenylacetyl (NP) coupled to chicken
 globulin (NP-CGG) or Ficoll (NP-Ficoll) to elicit T cell-sette. Absence of Bam32 protein expression was con-
firmed by Western blotting on B lymphocyte extracts dependent or T cell-independent immune responses,
respectively. We found no deficiency in T cell-dependentwith a polyclonal antibody raised against full-length
Bam32 (Figure 2C). No additional bands that might rep- immune responses as measured by specific IgM and
IgG1 responses (Figure 4A). In addition, sequencing ofresent aberrant forms of Bam32 were detectable in
Bam32/ lysates. Flow cytometry revealed normal pro- the VH186.2 gene cloned from germinal center B cells
isolated from NP-CGG immunized mice revealed thatportions of pro-B, pre-B, immature, and recirculating B
cells in the bone marrow, and normal proportions of somatic hypermutation was normal (Bothwell et al., 1981;
data not shown). In contrast, T cell-independent immunetype 1 and type 2 transitional (T1 and T2, respectively),
marginal zone, and follicular B cells in spleen (Figure responses were disabled in Bam32/ mice. The NP-
specific IgM response was reduced 2- to 3-fold, and,3A). The only B cell subset affected by Bam32 deficiency
more impressive, the IgG3 response was reduced 14-was peritoneal B-1a B cells, which were 3- to 5-fold
fold (Figure 4B). Thus, Bam32/ B cells are defectivereduced (Figure 3A, lower left). We also found normal
in T cell-independent but not in T cell-dependent re-numbers of total cells and B cells in the bone marrow
sponses to antigen in vivo.and spleen (Supplemental Table S1 [http://www.immunity.
com/cgi/content/full/19/4/621/DC1]). Consistent with
the normal numbers of B cells, Bam32/ mice had nor- Bam32 Mediates BCR-Induced B Cell Proliferation
mal serum antibody levels (Figure 3B). We conclude To determine whether Bam32/ B cells show a cell
that Bam32 is not required for most aspects of B cell autonomous defect in response to BCR stimulation, we
development but is required for normal development or purified B cells and stimulated them with anti-IgM or
various B cell mitogens in vitro. We found that Bam32/maintenance of the peritoneal B-1a compartment.
Bam32 Is Required for BCR-Induced Proliferation
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Figure 2. Targeting the Bam32 Locus
(A) The endogenous Bam32 locus (top), the
targeting construct (middle), and the targeted
locus (bottom). Relevant HindIII sites, probe
region, and size of the bands expected in
Southern blotting are indicated.
(B) Southern blot analysis of HindIII-digested
ES cell DNA using the probe indicated in (A).
The wild-type allele is 2.1 kb while the mutant
allele is 1.5 kb. An untargeted clone is in-
cluded as a control.
(C) Western blot analysis for Bam32 expres-
sion in whole-cell lysates of purified splenic B
cells from wild-type and Bam32/ mice using
anti-Dapp1/Bam32 antibody (Babraham).
B cells responded normally to anti-IgM by upregulating 5C). We found no differences in survival between
Bam32/ and wild-type B cells cultured in the absenceMHCII and CD86 expression (Figure 5A), but proliferative
response to anti-IgM stimulation was severely impaired of mitogens or with anti-IgM, LPS, IL-4, anti-CD40, anti-
IgM  IL-4, or anti-IgM  anti-CD40, after 24, 48, or 72(Figure 5B). Bam32/ B cells essentially failed to divide
at doses of 0.6 g/ml and 1.2 g/ml of anti-IgM, while hr of culture, while PKC/ cells included as a control
were clearly impaired in survival (Figure 5C and datawild-type B cells underwent multiple divisions (Figure 5B).
At saturating doses of anti-IgM (10 g/ml), Bam32/ B not shown). We conclude that Bam32/ B cells differ
from previously characterized BCR signaling mutants incells did divide but to a lesser extent than wild-type B
cells (Figure 5B). The decreased proliferative response that they show a defect in proliferative responses to
BCR crosslinking without an associated increase into anti-IgM was not the result of an intrinsic defect in
B cell response to mitogens, as we found normal cell cell death.
division after stimulation of knockout B cells with LPS,
anti-CD40, anti-CD40  IL-4, anti-RP105, anti-CD38, Bam32 Links the BCR to ERK and JNK
To determine which signaling pathways are affected byand CpG (Figure 5B and data not shown). No defects
in proliferation were observed at suboptimal doses of Bam32, we performed biochemical analysis of mutant
B cells. BCR proximal signaling was initially evaluatedLPS or anti-CD40 in Bam32/ B cells (Supplemental
Figure S2 [http://www.immunity.com/cgi/content/full/19/ by measuring protein tyrosine phosphorylation and Ca2
flux responses. Consistent with the normal upregulation4/621/DC1]). Finally, the defective response to anti-IgM
was complemented by costimulation with either IL-4 or of MHCII and CD86 in response to anti-IgM, we found no
significant differences in either tyrosine phosphorylationanti-CD40 (Figure 5B). Thus, signaling pathways in-
duced by LPS, IL-4, anti-CD40, anti-CD38, anti-RP105, or Ca2 flux (Figures 6A and 6B). This suggests Bam32
is not essential for activation of proximal elements ofand CpG are unaffected by Bam32 deletion. In addition,
Bam32 is not required for BCR-mediated upregulation the BCR signaling cascade including src family and Syk
kinases, PI3K, Btk, and PLC2. AKT and NFB are down-of MHCII and CD86. Bam32 specifically affects BCR-
mediated proliferation. stream of PI3K and have been implicated in regulating
B cell survival (Kaisho et al., 2001; Pasparakis et al.,Mutations in all previously characterized BCR signal-
ing components that impede proliferation also affect B 2002; Pogue et al., 2000). In agreement with the observa-
tion that Bam32/ B cells survive normally in culture,cell survival (Clayton et al., 2002; Fruman et al., 2000,
1999; Kaisho et al., 2001; Khan, 2001; Kurosaki, 2000; in response to BCR stimulation, we found normal phos-
phorylation of AKT and an intact NFB pathway as as-Maas and Hendriks, 2001; Niiro and Clark, 2002; Okken-
haug et al., 2002; Pasparakis et al., 2002; Pogue et al., sessed by phosphorylation of IKK/and IB and degra-
dation of IB (Figure 6C).2000; Saijo et al., 2002). To determine whether the
Bam32 mutation is also associated with altered B cell In chicken DT40 cells, Bam32 was found to regulate
MAPKs, and these enzymes are implicated in regulatingsurvival, we stained cultured cells with a combination
of 7-amino-actinomycin D (7-AAD) and Annexin V (Figure BCR-mediated proliferative responses (Kurosaki, 2000;
Immunity
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Figure 3. B Cell Development and Serum An-
tibody Titers in Bam32/ Mice
(A) Flow cytometric analysis of cells from the
bone marrow (upper left), spleen (right), and
peritoneal cavity (lower left). Staining anti-
bodies are indicated adjacent to the axis.
Cells within the lymphocyte gate are shown,
and further gating is indicated directly above
the dot plots where applicable. Numbers
show relative percentages of cells within indi-
cated gates. In the bone marrow: top row,
staining for pro-B cells (IgM, CD43, B220)
and pre-B cells (IgM, CD43, B220); middle
row, staining for pre-B (B220lo, CD25, IgM)
and immature B cells (B220lo, CD25, IgM);
bottom row, staining for pro/pre-B (B220lo,
IgM), immature (B220lo, IgM), and mature
recirculating (B220hi, IgM) B cells. In the
spleen: top row, staining for immature (B220lo,
IgM) and mature (B220hi, IgM) B cells; sec-
ond row, staining for transitional type-2 B
cells (CD23, CD21, IgM); third row, stain-
ing for marginal zone (CD23, CD21, IgM)
and transitional type-1 (CD23, CD21, IgM)
B cells; bottom row, staining for immature
(IgMhi, IgDlo) and mature (IgMlo, IgDhi) B cells.
In the peritoneal cavity: staining for B-1a cells
(CD5, IgM). Each dot plot shown is repre-
sentative of at least three independent exper-
iments.
(B) Serum Ig concentrations (g/ml) in age-
and sex-matched Bam32 mutant and wild-type
mice. Individual wild-type mice are represented
by circles, and individual knockout mice are
represented by triangles. Mean values are in-
dicated by bold lines.
Niiro and Clark, 2002; Niiro et al., 2002; Richards et al., MAPK kinase (MAP2K) superfamily and are known to
activate ERK. We found that MEK1/2 phosphorylation,2001). To determine whether Bam32 regulates MAPKs
in mouse B cells, we measured activation of extracellular and therefore activation, in response to anti-IgM stimu-
lation was severely impaired in Bam32-deficient B cellssignal-regulated kinase (ERK), c-jun NH2-terminal ki-
nase (JNK), and p38 mitogen-activated protein kinase (Figure 7B). We conclude that BCR signals leading to
MEK1/2 and kinases downstream of MEK1/2 are im-(p38) in response to anti-IgM stimulation in Bam32/
B cells and controls. Western blot analysis showed that paired in the absence of Bam32.
MEK1/2 are activated by members of the MAPKK ki-ERK and JNK phosphorylation, and therefore activation,
was reduced for all doses of anti-IgM tested, but p38 nase (MAP3K) superfamily including Raf and MEKK1
(Brummer et al., 2002; Lange-Carter et al., 1993; Yujiriwas unaffected in the absence of Bam32 (Figure 7A,
Supplemental Figure S2 [http://www.immunity.com/cgi/ et al., 1998). To determine which of these is linked to
the Bam32 pathway, we measured their activation incontent/full/19/4/621/DC1]).
To determine how Bam32 might be linked to ERK and response to BCR stimulation in Bam32/ B cells and
controls. We found no defect in Raf activation inJNK, we examined MAPK kinases upstream of ERK and
JNK. MAPK/ERK kinases (MEK1/2) are members of the Bam32/ B cells in response to receptor stimulation as
Bam32 Is Required for BCR-Induced Proliferation
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Figure 4. Responses to Immunization in Bam32 Knockout Mice
(A) Serum NP-specific response to immunization with TD antigen NP-CGG as determined by ELISA. Individual wild-type mice (circles) and
Bam32 knockout mice (triangles) were immunized, and serum antibodies were assessed at various time points, as indicated on the x axis.
The mean antibody levels are indicated for wild-type (solid line) and knockout mice (dashed line). Levels reflect relative binding of serum IgM
(left) or IgG1 (right) to NP2-BSA, within the linear range when compared to a standard. Samples with antibody levels below detection threshold
are represented as ND (none detected).
(B) Serum NP-specific response to immunization with TI antigen NP-Ficoll. Levels reflect relative binding of serum IgM (left) or IgG3 (right) to
NP2-BSA. Samples with antibody levels below detection threshold are represented as ND (none detected).
measured by Western blotting for phosphorylated Raf Bam32 immunoprecipitates of Bam32/ B cell lysates
(Supplemental Figure S3 [http://www.immunity.com/cgi/(Figure 7B). In contrast, MEKK1 kinase activation in
Bam32/ B cells was diminished when compared to content/full/19/4/621/DC1]). We conclude that Bam32
associates with HPK1, and Bam32/ B cells are im-wild-type controls (Figure 7B). We conclude that signal-
ing pathways leading to MEKK1 activation are impaired paired in HPK1 kinase activation.
in the absence of Bam32.
MEKK1 and other MAP3Ks are activated by Ste20 Discussion
family kinases that act as MAP3K kinases (MAP4K). He-
matopoietic progenitor kinase 1 (HPK1) is one such In the absence of Bam32, B cells develop normally in
the bone marrow and spleen, but there is a deficiencyMAP4K which is expressed in B cells (Hu et al., 1996;
Kiefer et al., 1996; Liou et al., 2000). To determine in the peritoneal B-1a cell compartment. The selective
B-1a deficiency is in agreement with the idea that BCRwhether HPK1 activation is impaired in the absence of
Bam32, we performed kinase assays on Bam32/ and crosslinking by self-antigen is required for maintenance
of this self-renewing B cell compartment (Hardy andcontrol B cells after BCR stimulation. We found that
HPK1 kinase was less active in response to BCR cross- Hayakawa, 2001). Normal B cell development in the ab-
sence of Bam32 is consistent with the finding that thelinking in the absence of Bam32 (Figure 7B). To deter-
mine whether Bam32 interacts with HPK1, we performed Bam32 mutation has no effect on B cell survival and the
idea that the role of BCR signaling in development is toimmunoprecipitation experiments using the human B
cell line BJAB. We found that Bam32 was coimmuno- maintain B cell survival through inhibition of proapo-
ptotic signals (Lam et al., 1997; Meffre and Nussenzweig,precipitated with HPK1, and conversely that HPK1 was
coimmunoprecipitated with Bam32; this association 2002; Rajewsky, 1996).
Adaptor proteins diversify cellular signaling by linkingwas independent of BCR crosslinking (Figure 7C). This
association was confirmed in mouse splenic B cells different groups of signaling proteins (Jordan et al.,
2003; Kelly and Chan, 2000; Kurosaki, 2002). Bam32, anwhere HPK1 was also coimmunoprecipitated with Bam32
(Figure 7D). As a further control, we performed parallel adaptor implicated in BCR signaling, is composed of an
SH2 and a PH domain and is recruited to the membranecoimmunoprecipitation experiments in Bam32 knockout
mice and found that HPK1 was not detectable in anti- by PI3K activation (Anderson et al., 2000; Marshall et
Immunity
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Figure 5. Responses of Bam32 Knockout B Cells to Stimulation In Vitro
(A) Activation of wild-type and knockout B cells in response to 1.2 g/ml anti-IgM as assessed by MHCII upregulation (left) and CD86
upregulation (right). Histograms represent Class II or CD86 expression with stimulation (filled plot) and without (unfilled plot). Data shown are
representative of three independent experiments.
(B) Proliferative responses of CFSE-labeled B cells from wild-type and knockout mice incubated for 72 hr in the presence of indicated
mitogenic stimuli. Number of cell divisions as assessed by CFSE dye dilution is indicated on the x axis. Data shown are representative of
four independent experiments.
(C) Cell survival as determined by flow cytometric analysis on isolated splenic B cells cultured in the presence of indicated mitogens for 48
hr. Cells negative for 7-AAD and Annexin V staining were scored as viable. Numbers show percentage of viable cells. Black bars show wild-
type, light gray bars show Bam32/, and dark gray bars show PKC/ B cells, included as a control. Results represent the mean of two
experiments, and the variation between experiments was less than 10%.
al., 2000a). Based on studies in DT40 cells, it was initially as opposed to chicken B cells. Others have demon-
strated such redundancy in mutant mouse models, in-proposed that Bam32 mediates Ca2 flux through PLC2
and consequently, NFB and MAPK activation and cell cluding Syk/Zap70 and Btk/Tec double mutants and Src
family kinase triple mutants (Ellmeier et al., 2000; Saijosurvival (Marshall et al., 2000a; Niiro et al., 2002). How-
ever, the function of Bam32 and its relation to PLC2 et al., 2003; Schweighoffer et al., 2003). The differences
may also reflect aberrant responses in transformedwas unclear in DT40 cells. Bam32-deficient DT40 cells
exhibit only mild impairment in PLC2 phosphorylation DT40 cells, or intrinsic differences between chicken
DT40 and mouse B cells in response to BCR stimulation.and Ca2 flux in response to BCR stimulation (Niiro et al.,
2002). Furthermore, in response to anti-IgM stimulation, For example, it is not possible to measure proliferation
in response to BCR stimulation in DT40 cells. In contrastapoptosis is impaired in PLC2-deficient DT40 cells,
while apoptosis is enhanced in Bam32-deficient DT40 to splenic mouse B cells which undergo proliferation,
DT40 cells undergo apoptosis in response to BCR stimu-cells (Niiro et al., 2002; Takata et al., 1995). In mice,
we found no defects in Ca2 flux or NFB activation in lation, mimicking elimination of self-reactive B cells
(Takata et al., 1995). Our findings in mice that Bam32 isBam32/ B cells and no direct link between Bam32
and PLC2. The observed differences between the data not linked to PLC2, Ca2 flux, or NFB activation are
consistent with our observations that Bam32/ B cellspresented here and previous data from DT40 cells may
reflect redundancy of signaling pathways in mammalian show no evidence of increased cell death in vivo or in
Bam32 Is Required for BCR-Induced Proliferation
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Figure 6. BCR-Mediated Signaling in Bam32/ B Cells
(A) Western blot analysis for tyrosine phosphorylated proteins in isolated splenic B cells from knockout and wild-type mice when stimulated
with anti-IgM. Cell lysates were subject to Western blotting with anti-phophotyrosine. Blot was probed for actin for loading control. Data are
representative of two experiments.
(B) Calcium Flux analysis in response to BCR stimulation is wild-type (top) and knockout (bottom) B cells. Flow cytometry analysis depicting
calcium flux (y axis) as a function of time (x axis) in cells stimulated with either 0.6 g/ml (lower lines within plot), 1.2 g/ml (middle line), or
10 g/ml (upper line) of anti-IgM. Arrows indicate time point of simulation. Data shown are representative of three independent experiments.
(C) Western blot analysis to detect BCR-induced phosphorylation of Akt (top), IKK/ (middle), and IB (bottom), and degradation of IB
(bottom) in response to BCR stimulation. For loading control, blots were probed to detect total AKT, IKK/, and actin. Data shown are
representative of two (NF-B pathway) or three (AKT) independent experiments.
vitro. We propose that Bam32 affects MAPK activation development, proliferation, and survival (Clayton et al.,
2002; Doody et al., 2001; Fruman et al., 1999; Jumaa etthrough means independent of PLC2.
PI3K is a central effector of BCR signaling that ampli- al., 1999; Khan et al., 1995; Maas and Hendriks, 2001;
Okkenhaug et al., 2002; Saijo et al., 2002; Tedford et al.,fies cellular signaling responses by producing phopho-
inositol 3,4,5-triphosphate (PtdInsP3) (Kurosaki, 2000; 2001; Wang et al., 2000; Xu et al., 2000; Yamazaki et al.,
2002). In contrast, the isolated defects in proliferationNiiro and Clark, 2002; Okkenhaug and Vanhaesebroeck,
2003). This second messenger in turn mediates several and B-1a cell maintenance which we observe in Bam32
knockout mice are unlike those of the aforementionedparallel signaling cascades including those of AKT and
PLC2 (Kurosaki, 2000; Niiro and Clark, 2002; Okken- xid-like mutants, suggesting that Bam32 activates a pre-
viously unappreciated pathway from PI3K to the nucleushaug and Vanhaesebroeck, 2003). PLC2 further diversi-
fies signals by producing the additional second messen- which clearly differs from pathways affected by xid-
like mutations.gers inositol 1,4,5-triphosphate and diacylglycerol,
which induce Ca2 flux and activate PKCs, and therefore A number of signaling pathways triggered by the BCR
are believed to converge on activation of MAPKs includ-NFB (Marshall et al., 2000b; Saijo et al., 2002). Given
the importance of AKT and NFB in cell survival (Kaisho ing a PLC-2-dependent pathway that is essential for
activation of JNK and p38, and a PLC-2-independentet al., 2001; Pasparakis et al., 2002; Pogue et al., 2000),
it is not surprising that numerous mouse mutations in pathway to ERK that is poorly understood but is essen-
tial for BCR-induced B cell proliferation in mature B cellsPI3K-related signaling proteins such as Btk, PKC,
BLNK/SLP-65, PLC-2, Vav1/Vav2, BCAP, and PI3K (Hashimoto et al., 1998; Ishiai et al., 1999; Richards et
al., 2001). We propose that PI3K initiates a novel PLC2-subunits p85 and p110	 are characterized by X-linked
immunodeficiency-like (xid-like) defects (Fruman et al., independent pathway to ERK and JNK activation that
functions through Bam32 and provide evidence that this2000; Khan, 2001; Maas and Hendriks, 2001) in B cell
Immunity
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Figure 7. MAP Kinase Pathways in Bam32/ B Cells
(A) Western blot analysis for phophorylated ERK, JNK, and p38 MAPK in isolated splenic B cells. B cells from knockout and wild-type control
mice were stimulated with anti-IgM and lysed at different time points. Blots were reprobed to detect total ERK, JNK, and p38. Numbers reflect
the relative intensity of bands representing phosphorylated active protein in relation to total protein. Data shown are representative of three
(ERK, p38) or four (JNK) independent experiments.
(B) Raf, MEK1/2, MEKK1, and HPK1 activation. Western blot analysis for phosphorylated forms of Raf and MEK1/2 (upper) and in vitro kinase
assay performed on immunoprecipitated MEKK1 and HPK1 using MBP substrate (lower). For Raf and MEK1/2, numbers reflect relative intensity
of bands representing phorphorylated active protein in relation to total protein. For MEKK1 and HPK1, numbers reflect the relative kinase
activity in relation to protein levels. Data shown are representative of three independent experiments.
(C) Bam32 and HPK1 coimmunoprecipitation in BJAB. Immunoprecipitation on BJAB lysates using anti-Bam32 (left half of blots) or anti-
HPK1 (right half of blots), probed with anti-Bam32 (left blot) or anti-HPK1 (right blot). Bands representing Bam32 or HPK1 and control
immunoprecipitations performed with species-matched control antibodies are indicated. Data shown are representative of four indepen-
dent experiments.
(D) Bam32 and HPK1 coimmunoprecipitation in mouse splenic B cells. Lysates were immunoprecipitated using anti-HPK1 (left half) or anti-
Bam32 (right half) and probed with anti-HPK1. Data shown are representative of two independent experiments.
pathway functions through intermediates MEK1/2 and largely restricted to hematopoietic cells. Here, we pro-
vide evidence that Bam32 physically interacts withMEKK1. MEKK1 is selective for ERK and JNK but not
p38, and activates ERK through MEK1/2 (Schlesinger HPK1 and that HPK1 kinase activity is impaired in Bam32
mutant B cells. These data suggest a means throughet al., 1998; Yujiri et al., 1998). MEKK1 is not the only
enzyme that can activate MEK1/2: Raf is an additional which Bam32 may affect MEKK1 activation.
Numerous groups have reported HPK1 as a positiveMAP3K implicated in BCR-mediated proliferation, but
we find that Raf activation does not require Bam32 regulator of JNK (Hu et al., 1996; Kiefer et al., 1996;
Liou et al., 2000) However, with regard to ERK, it was(Brummer et al., 2002; Lange-Carter et al., 1993).
The means through which MEKK1 is activated is previously reported that HPK1 does not affect ERK in
B cell lines, but negatively regulates ERK and AP-1 inpoorly understood. HPK1 is member of the Ste20 group
kinases, which may function as a MAP4K (Hu et al., T cell lines (Liou et al., 2000; Tsuji et al., 2001). HPK1
has also been implicated in NFB signaling both as a1996; Kiefer et al., 1996). HPK1 has been implicated in
MEKK1 activation, and, like Bam32, its expression is positive and negative regulator (Arnold et al., 2001; Hu
Bam32 Is Required for BCR-Induced Proliferation
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Flow Cytometryet al., 1999; Tsuji et al., 2001). These differences may
Single-cell suspensions from indicated organs were depleted ofbe due to caspase-mediated cleavage of HPK1, which
erythrocytes by lysis in ACK buffer (0.155 M ammonium chloride,can modulate its activity (Arnold et al., 2001; Chen et al.,
0.1 mM disodium EDTA, and 0.01 M potassium bicarbonate). 1 

1999). HPK1 has also been shown by others to associate 106 cells per condition were stained with antibodies conjugated to
with numerous other adaptors in different cell types, fluorescein isothiocyanate (FITC), phycoerythrin (PE), allophycocy-
anin (APC), or biotin. Biotin conjugates were visualized with eitherincluding BLNK (Ensenat et al., 1999; Ling et al., 2001,
Red670-streptavidin (GIBCO-BRL, Rockville, MD) or PE-Cy7-strep-1999; Liou et al., 2000; Sauer et al., 2001; Tsuji et al.,
tavidin (Caltag). The following anti-mouse mAbs (BD Pharmingen)2001). Bam32 may direct localization of HPK1 to the
were used: anti-B220 (RA3-6B2), anti-CD43 (S7), anti-IgM (R6-60.2),plasma membrane, thereby allowing activation of MEKK1
anti-IgD (11-26c.2a), anti-CD21 (7G6), anti-CD23 (B3B4), and anti-
without significantly altering the function of HPK1 in CD25 (PC61). Data were collected on a FACS Calibur cytometer and
other parallel pathways. Consistent with this idea, our analyzed with Cellquest software (Becton Dickinson). For Calcium
flux analysis, cells were loaded in 2 M Indo 1 (Molecular Probes).data show a comparatively mild impairment in HPK1
B cells were gated with anti-B220 and cells were stimulated withactivity in Bam32/ B cells. It is also possible that
indicated concentrations of F(ab)2 anti-mouse IgM (Jackson Immu-Bam32 affects MEKK1 through other MAP4Ks, indepen-
noresearch). Data were acquired on a BD LSR cytometer (Bectondently of HPK1. Thus, the precise relationship between
Dickinson) and analyzed with FloJo software (Treestar).
Bam32 and HPK1 as it pertains to MAPK activation re-
mains to be determined. In Vitro Survival, Proliferation, and Activation
The Bam32 pathway to MAPKs is not directly linked B cells were purified from spleen by depletion of CD43-expressing
cells with anti-CD43 magnetic beads (MACS; Miltenyi Biotec). Forto NFB, AKT, or Ca2 flux, and therefore disruption of
proliferation analysis, 1 
 107 cells/ml in RPMI were labeled with 5this arm of BCR signaling does not affect cell survival.
M CFSE for 10 min at 37C. Cells were cultured in RPMI containingIn addition, PI3K-independent pathways to MAPK acti-
10% FCS, 2 mM L-glutamine, 100 U/ml penicillin, 100 g/ml strepto-vation should not be affected by Bam32 deficiency. In-
mycin, and 50 M 2-mercaptoethanol. Cells were stimulated with
deed, complementation of the Bam32 deficiency by anti- 0.6, 1.2, or 10 g/ml (as indicated) of F(ab)2 fragment goat anti-
CD40 or IL-4 in vitro is likely to result from ERK and JNK mouse IgM (Jackson Immunoresearch), 0.6 g/ml anti-CD40 anti-
body (HM40-3; BD Pharmingen), 5 g/ml lipopolysaccaride (LPS;activation through such alternative means. This may
Sigma), 25 U/ml recombinant mouse IL-4 (Genzyme), or with combi-also explain why Bam32/ mice show normal T-depen-
nations as indicated. For survival analysis, cells were washed indent antibody responses in vivo.
Annexin V binding buffer (10 mM HEPES [pH 7.5], 140 mM NaCl, 5
mM KCl, 1 mM MgCl2, 1.8 mM CaCl2) and stained with Annexin V
biotin (Roche) and 7-aminoactinomycin D (7-AAD, Sigma). CellsExperimental Procedures
were analyzed by flow cytometry as previously indicated. For activa-
tion, cells were stained 24 hr after culture with anti-CD86 (BD Phar-Bam32-Deficient Mice
mingen) or anti-MHCII (M5/114).Bam32 knockout mice carry a Bam32 gene in which exon 1 is re-
placed by a neomycin resistance cassette. The genomic DNA used
Immunizationsfor targeting was derived from a BAC genomic clone (Research
Age- and sex-matched 8- to 12-week-old C57BL/6 control miceGenetics). The long arm of the targeting vector was 8 kb of DNA 5
(Jackson Labs) and C57BL/6 congenic Bam32/ mice were injectedof the first codon, and the short arm was 750 bp of DNA 3 to exon
intraperitoneally with either 12.5 g of NP190-Ficoll or 50 g of alum1. A neomycin resistance cassette inserted between the long and
precipitated NP21-CGG (both from Biosearch Technologies) in 300short arms was used for positive selection. Exon 1 encodes a con-
l of PBS. Doses within the linear range by ELISA (see below) wereserved amino acid sequence and the beginning of the SH2 domain.
determined by titration of antigen and immunizations in wild-typeStop codons are present in all reading frames 3 to the neo cassette,
mice. Mice were bled from the tail vein at various time points as indi-and no in-frame methionines are present until the end of the consen-
cated.sus SH2 domain. No aberrant splice products were detectable in RT-
PCR reactions using primers derived from Bam32 5 untranslated
sequences upstream of the Neo cassette or using primers derived ELISA
Unimmunized age- and sex-matched 8- to 12-week-old C57BL/6from within the Neo cassette. A diphtheria toxin gene, inserted distal
to the short arm, was used for negative selection (Yagi et al., 1990). control mice and C57BL/6 congenic Bam32/ mice were bled and
ELISA was carried out using unlabeled goat anti-mouse Ig (HL)A HindIII site, engineered within the neomycin resistance cassette,
was used for screening purposes. The targeting construct was trans- for capture and HRP-conjugated goat anti-mouse isotype-specific
antibodies (Southern Biotechnology) for detection. Plates were de-fected into E14 (129/Ola) embryonic stem (ES) cells; G418 resistant
clones were screened for homologous recombination by PCR and veloped using a Peroxidase Substrate Kit (Bio-Rad) and absorbance
measured at 415 nm. Values were compared to mouse immunoglob-confirmed with Southern blot analysis on HindIII-digested DNA. The
genomic fragment used as a probe for Southern blotting was gener- ulin standards (Southern Biotechnology). The relative amount of NP-
specific immunoglobulin was measured using NP2-BSA (Biosearchated by PCR with the primers 5-TACTGTCCCTTGCATAGGATGGC-
Technologies) as the coating antigen. Plates were coated at 4C for3 and 5-GTCTGACATATCATCTGTGTGGAG-3. Following diges-
15 hr with 100l of PBS containing 5g/ml NP2-BSA. Serial dilutionstion with HindIII, the wild-type allele gives a 2.1 kb fragment while
were performed for each sample and a standard control. Platesthe knockout allele gives a 1.5 kb fragment. Mice were genotyped
were developed as described above. Results reflect relative ab-by PCR with the following primers: 5-CCTCTTACTCACAGCCGTGT
sorbance for each sample compared with the standard control.AGT-3 (common), 5-CGAGCACGTACTCGGATGGAAG-3 (targeted)
Readings were taken within the linear range for each sample, andand 5-ATGGGCAGAGCAGAACTTCTAGGA-3 (wild-type). A PCR
adjusted for dilution.product of approximately 500 bp represents the wild-type allele,
while a product of approximately 850 bp represents the knockout
allele. Positive ES cell clones were injected into C57BL/6 blasto- Western Blotting, Immunoprecipitation, and In Vitro Kinase Assay
cysts. Mice were backcrossed to C57BL/6 for 10 generations during To confirm the absence of Bam32 protein in knockout mice, 1 

time of analysis. Data presented here reflect experiments performed 107 splenic B cells were prepared in 1% NP-40 lysis buffer (50 mM
on either C57BL/6 congenic Bam32 knockout mice with age- and Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, and 10%
sex-matched controls, or on littermates. All mice were bred and Glycerol) supplemented with a protease inhibitor cocktail (Sigma).
maintained under specific pathogen-free conditions, and all mouse Lysates were resolved on a 4%–12% NuPage gel (Invitrogen) and
transferred onto Immobilon-P membranes (Millipore). Western blot-protocols were approved by the Rockefeller University IACUC.
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